Security
China Pharma Holdings, Inc. · CPHI
CPHINYSE_AMERICANCommon stockCurrentCIK 1106644Updated Nov 2, 2026
Name history
TS ELECTRONICS INC · through May 4, 2006SOFTSTONE INC · through Aug 18, 2003SOFTSTONE INC /DE/ · through Jan 27, 2003KILKENNY ACQUISITION CORP · through Mar 30, 2001
CPHI price & chart
Loading TradingView…
AMEX:CPHI on TradingView ↗About the company
China Pharma Holdings, Inc. is a specialty pharmaceutical company that develops, manufactures and markets a diversified portfolio of products focused on conditions with a high incidence and high mortality rates in China, including cardiovascular, CNS, infectious, and digestive diseases. The Company’s cost-effective, high-margin business model is driven by market demand and supported by eight scalable GMP-certified product lines covering the major dosage forms. In addition, the Company has a broad and expanding nationwide distribution network across all major cities and provinces in China. The Company’s wholly-owned subsidiary, Hainan Helpson Medical & Biotechnology Co., Ltd., is located in Haikou City, Hainan Province. For more information about China Pharma Holdings, Inc., please visit http://www.chinapharmaholdings.com. The Company routinely posts important information on its website.
In the news
China Pharma Holdings, Inc. Comments on Unusual Market Activity ↗
Seeking Alpha
At a glance: stocks gapping down premarket ↗
Recent filings
PRE 14A filing
10-Q filing
424B5 filing
Entry into a Material Definitive Agreement · Other Events
Items 1.01, 8.01, 9.01
10-Q filing
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 15,804,793Source | 13,465,610Source | 44,709,903Source | 13,766,560Source | 14,261,233Source | 45,143,790Source | 14,217,073Source | — | 30,999,464Source | 14,887,524Source | 16,469,200Source | 17,784,143Source |
| Property, Plant and Equipment, NetUSD | 4,502,479Source | 5,305,709Source | 4,219,763Source | 4,625,907Source | 5,817,379Source | 4,303,993Source | 4,777,100Source | — | 4,391,964Source | 4,883,401Source | 7,100,425Source | 9,973,065Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 8,775,036Source | 4,361,993Source | 38,337,341Source | 6,439,862Source | 4,393,617Source | 38,674,367Source | 6,569,921Source | — | 24,079,265Source | 6,695,436Source | 3,255,232Source | 1,807,486Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 267,625Source | 700,000Source | 304,874Source | 600,000Source | — | 168,474Source | 400,000Source | — | 345,112Source | 600,000Source | 1,423,838Source | 2,029,971Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 224,638Source | 333,371Source | 181,621Source | 268,793Source | 254,850Source | 196,262Source | 328,901Source | — | 241,412Source | 232,140Source | 504,448Source | — |
| Inventory, NetUSD | 1,649,682Source | 2,498,851Source | 1,362,423Source | 1,678,769Source | 2,818,925Source | 1,498,501Source | 1,978,918Source | — | 1,621,423Source | 2,266,154Source | 3,732,517Source | 2,947,787Source |
| Assets, CurrentUSD | 2,329,427Source | 3,738,977Source | 2,006,618Source | 2,700,791Source | 3,972,978Source | 2,003,555Source | 2,850,876Source | — | 2,346,407Source | 3,270,389Source | 5,996,933Source | 5,964,546Source |
| Operating Lease, Right-of-Use AssetUSD | 197,851Source | 58,931Source | 146,181Source | — | 77,259Source | 161,875Source | 19,176Source | — | 181,828Source | 38,298Source | 116,610Source | 39,046Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 7,490,796Source | 6,937,361Source | 8,528,623Source | 7,304,816Source | 6,852,711Source | 8,119,600Source | 7,247,225Source | — | 8,259,712Source | 7,139,620Source | 9,014,579Source | 13,494,145Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 5,022Source | 17,859Source | 40,522Source | 3,262Source | 17,162Source | 40,522Source | 3,262Source | — | 15,522Source | 32,618Source | 10,625Source | 74,909Source |
| Additional Paid in CapitalUSD | 43,076,319Source | 37,790,022Source | 73,504,819Source | 40,631,679Source | 37,690,719Source | 73,504,819Source | 40,631,679Source | — | 58,535,819Source | 40,602,323Source | 35,282,256Source | 28,853,520Source |
| Retained Earnings (Accumulated Deficit)USD | -45,992,100Source | -42,802,247Source | -49,815,506Source | -45,340,618Source | -41,684,336Source | -48,357,383Source | -44,812,251Source | — | -47,214,235Source | -44,026,679Source | -39,290,314Source | -36,211,496Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 11,404,756Source | 11,522,615Source | 12,631,445Source | 11,347,421Source | 11,384,977Source | 12,016,232Source | 11,327,158Source | — | 11,582,646Source | 11,319,642Source | 11,452,054Source | 11,573,065Source |
| Stockholders' Equity Attributable to ParentUSD | 8,313,997Source | 6,528,249Source | 36,181,280Source | 6,461,744Source | 7,408,522Source | 37,024,190Source | 6,969,848Source | 8,292,154Source | 22,739,752Source | 7,747,904Source | 7,454,621Source | 4,289,998Source |
| Liabilities and EquityUSD | 15,804,793Source | 13,465,610Source | 44,709,903Source | 13,766,560Source | 14,261,233Source | 45,143,790Source | 14,217,073Source | — | 30,999,464Source | 14,887,524Source | 16,469,200Source | 17,784,143Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 6,622,806Source | 4,760,209Source | 7,681,602Source | 5,250,655Source | 4,712,035Source | 7,267,678Source | 5,121,877Source | — | 7,400,359Source | 5,017,288Source | 6,820,664Source | 12,739,447Source |
| Operating Lease, Liability, CurrentUSD | 70,326Source | 60,241Source | 73,069Source | — | 78,628Source | 71,386Source | 19,776Source | — | 71,628Source | 39,323Source | 77,727Source | 40,445Source |
| Operating Lease, Liability, NoncurrentUSD | 128,257Source | — | 75,291Source | — | — | 92,294Source | — | — | 111,548Source | — | 39,910Source | — |
| Deferred Income Tax Liabilities, NetUSD | 739,733Source | 750,089Source | 771,730Source | 734,246Source | 737,522Source | 759,628Source | 732,241Source | — | 747,805Source | 731,202Source | 742,114Source | 754,698Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 170,426Source | 82,613Source | 500,160Source | 191,293Source | 208,831Source | 311,336Source | 195,264Source | — | 350,643Source | 247,159Source | 298,829Source | 404,807Source |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | — | — | — | -3,972,841Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 980,570Source | 329,313Source | 1,503,635Source | 2,618,066Source | 2,753,653Source | 2,700,533Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | — | — | 13,878,582Source | 0Source | 0Source | 0Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | -247,492Source | -156,627Source | -589,761Source | -1,606,888Source | 25,032Source | -689,104Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -55,292Source | -73,676Source | 148,261Source | -466,362Source | -699,686Source | -409,545Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | — | -58,324Source | -137,251Source | -291,718Source | -11,517Source | -401,964Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | — | 58,324Source | 59,324Source | 38,411Source | — | 401,964Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -79,325Source | -76,820Source | -294,027Source | 27,353Source | 73,145Source | -1,770,007Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -176,638Source | -214,191Source | -281,767Source | -796,959Source | -606,133Source | -2,829,088Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 267,625Source | 718,691Source | 304,874Source | 625,032Source | 168,474Source | 412,688Source | 345,112Source | 626,879Source | 1,423,838Source | 2,029,971Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 15,758Source | 21,241Source | 74,765Source | 86,765Source | 92,439Source | 141,797Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | — | — | — | -42,021Source | -5,371Source | 1,250Source | — | — | — |
| Additional Financial Items | ||||||||||||
| AmortizationUSD | — | — | — | — | — | — | — | — | 851,611Source | — | — | — |
| Amortization of Intangible AssetsUSD | — | — | 197,958Source | 104,845Source | 951,528Source | 157,360Source | 825,282Source | 157,712Source | 851,609Source | 447,246Source | 223,796Source | 36,558Source |
| DepreciationUSD | — | — | 158,076Source | 493,180Source | 150,327Source | 163,503Source | 155,288Source | 171,601Source | 652,026Source | 2,170,820Source | 2,529,858Source | 2,663,975Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | — | 137,638Source | — | — | — | — | — | — | -121,011Source | -990,764Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | — | — | — | — | -1,446Source | — | — | — | -45,385Source | — |
| General and Administrative ExpenseUSD | — | — | 424,827Source | 345,051Source | 1,376,974Source | 440,834Source | 1,226,272Source | 507,182Source | 2,451,459Source | 1,784,750Source | 1,466,084Source | 1,893,269Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | — | — | — | — | — | — | — | — | — | — | — | 1,807,486Source |
| Inventory Write-downUSD | — | — | — | — | — | — | — | 213,379Source | 549,218Source | 450,738Source | — | — |
| Investment Income, InterestUSD | — | — | — | 1,460Source | 81Source | 422Source | 147Source | 1,074Source | — | — | 6,602Source | 10,755Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -651,482Source | -1,117,911Source | -1,458,123Source | -528,367Source | -1,143,148Source | -785,572Source | -3,187,556Source | -4,736,365Source | -3,078,818Source | -3,972,841Source |
| Nonoperating Income (Expense)USD | — | — | -23,337Source | -32,654Source | -26,278Source | 123,753Source | -25,884Source | -26,954Source | 51,522Source | -147,499Source | -326,998Source | -423,864Source |
| Operating ExpensesUSD | — | — | 568,491Source | 565,608Source | 1,515,411Source | 565,110Source | 1,402,751Source | 622,557Source | 3,107,128Source | 2,603,218Source | 2,470,735Source | 3,055,061Source |
| Stock or Unit Option Plan ExpenseUSD | — | — | — | — | — | — | — | — | — | — | — | 78,270Source |
| Share-based Payment Arrangement, Noncash Expense | — | — | — | — | —Source | —Source | —Source | — | — | — | — | — |
| Share-based Payment Arrangement, Expense | — | — | — | — | — | — | — | — | — | — | — | — |
| InterestExpenseNonoperating | — | — | — | —Source | —Source | —Source | —Source | —Source | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 756,217Source | 1,100,152Source | 948,340Source | 1,025,767Source | 983,536Source | 1,136,287Source | 4,144,268Source | 4,528,929Source | 7,011,299Source | 8,104,092Source |
| Cost of Goods and Services Sold | — | — | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source |
| Operating Income (Loss)USD | — | — | -628,145Source | -1,085,257Source | -1,431,845Source | -652,120Source | -1,117,264Source | -758,618Source | -3,239,078Source | -4,588,866Source | -2,751,820Source | -3,548,977Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -651,482Source | -1,117,911Source | -1,458,123Source | -528,367Source | -1,143,148Source | -785,572Source | -3,187,556Source | -4,736,365Source | -3,078,818Source | -3,972,841Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -651,482Source | -1,117,911Source | -1,458,123Source | -528,367Source | -1,143,148Source | -785,572Source | -3,187,556Source | -4,736,365Source | -3,078,818Source | -3,972,841Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.17Source | -0.65Source | -0.04Source | -0.16Source | -0.04Source | -0.24Source | -0.74Source | -0.27Source | -0.91Source | -0.76Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.17Source | -0.65Source | -0.04Source | -0.16Source | -0.04Source | -0.24Source | -0.74Source | -0.27Source | -0.91Source | -0.76Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 3,874,085Source | 1,730,672Source | 40,522,002Source | 3,226,156Source | 25,602,002Source | 3,261,911Source | 4,291,427Source | 17,463,723Source | 3,383,573Source | 5,256,855Source |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 197,958Source | 104,845Source | 951,528Source | 157,360Source | 825,282Source | 157,712Source | 851,609Source | 447,246Source | 223,796Source | 36,558Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | — | 137,638Source | — | — | — | — | — | — | -121,011Source | -990,764Source |
| General and Administrative ExpenseUSD | — | — | 424,827Source | 345,051Source | 1,376,974Source | 440,834Source | 1,226,272Source | 507,182Source | 2,451,459Source | 1,784,750Source | 1,466,084Source | 1,893,269Source |
| Gross ProfitUSD | — | — | -59,654Source | -519,649Source | 83,566Source | -87,010Source | 285,487Source | -136,061Source | -131,950Source | -1,985,648Source | -281,085Source | -493,916Source |
| Interest ExpenseUSD | — | — | 6,798Source | 6,843Source | 9,306Source | 6,771Source | 9,085Source | 6,787Source | 27,272Source | 27,353Source | 333,600Source | 434,619Source |
| Interest Expense, DebtUSD | — | — | — | — | — | — | 6,476Source | 9,919Source | 32,237Source | — | 15,757Source | 93,851Source |
| Interest Income, OtherUSD | — | — | 294Source | 1,460Source | — | 422Source | — | 1,074Source | 2,003Source | 6,641Source | — | — |
| Investment Income, InterestUSD | — | — | — | 1,460Source | 81Source | 422Source | 147Source | 1,074Source | — | — | 6,602Source | 10,755Source |
| Nonoperating Income (Expense)USD | — | — | -23,337Source | -32,654Source | -26,278Source | 123,753Source | -25,884Source | -26,954Source | 51,522Source | -147,499Source | -326,998Source | -423,864Source |
| Operating ExpensesUSD | — | — | 568,491Source | 565,608Source | 1,515,411Source | 565,110Source | 1,402,751Source | 622,557Source | 3,107,128Source | 2,603,218Source | 2,470,735Source | 3,055,061Source |
| Research and Development ExpenseUSD | — | — | 40,321Source | 87,610Source | 19,135Source | 20,952Source | 83,762Source | 29,587Source | 280,901Source | 283,942Source | 240,080Source | 185,858Source |
| Selling ExpenseUSD | — | — | 78,041Source | 134,603Source | 113,764Source | 101,292Source | 95,598Source | 87,111Source | 375,786Source | 528,824Source | 780,328Source | 1,069,785Source |
| Weighted Average Number of Shares Outstanding, Diluted | — | — | — | — | —Source | —Source | —Source | —Source | — | — | — | — |
| Interest Expense (non-operating) | — | — | — | —Source | —Source | —Source | —Source | —Source | — | — | — | — |
| Depreciation, Depletion and Amortization, Nonproduction | — | — | — | — | — | — | —Source | —Source | — | — | — | — |
Filing attachments
ea029892101ex99-1.htm · 8-K · 2026-07-22
EX-99.1 5 ea029892101ex99-1.htm PRESS RELEASE DATED AS OF JULY 22, 2026 Exhibit 99.1 China Pharma Announces Pricing of $5 Million Registered Direct Offering HAIKOU CITY, China, July 22, 2026 - China Pharma Holdings, Inc. (NYSE American: CPHI) (“China Pharma” or the “Company”), a fully-integrated specialty pharmaceuticals company in China, today announced that the pricing of its registered direct offering of 2.5 million shares of its common stock (“Common Shares”), at a purchase price of $2…
Read attachment ↗ea023720801ex99-1_china.htm · 8-K · 2025-04-04
EX-99.1 2 ea023720801ex99-1_china.htm PRESS RELEASE, DATED APRIL 4, 2025 Exhibit 99.1 China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split Haikou City, China, April 4, 2025 - China Pharma Holdings Inc. (“China Pharma” or the “Company”) (NYSE American: CPHI) reported that it expects to implement a 1-for-10 reverse stock split on its common stock effective Tuesday, April 15, 2025, with trading to begin on a split-adjusted basis at the market open on that day. Trading in the comm…
Read attachment ↗